Once-Yearly Aclasta® Approved In EU To Treat Male Osteoporosis And To Reduce Risk Of New Fractures Following Hip Fracture In Both Sexes

The European Commission has approved once-yearly Aclasta®* (zoledronic acid 5 mg) for the treatment of osteoporosis in men who are at increased risk of fractures.

New Surgical Interference Screw Provides Secure, Versatile, Bioabsorbable Fixation in ACL Repair

Smith & Nephew’s Endoscopy Division has announced the launch of its bioabsorbable BIOSURE™ HA Interference Screw line for use in Anterior Cruciate Ligament (ACL) and Posterior Cruciate Ligament (PCL) reconstruction.

Alcon Launches New AcrySof® ReSTOR® Intraocular Lens for Presbyopia Outside the U.S.

Alcon, Inc. announced the commercial launch outside the U.S. of the new +3.0 Add Power AcrySof® ReSTOR® Aspheric IOL during the 2008 European Society of Cataract and Refractive Surgeons (ESCRS) meeting in Berlin, Germany

Most read

Latest

^